Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

Diabetes Research and Clinical Practice

Volumn 95, Issue 3, 2012, Pages

  Dash, Satya ^a,b   Crisp, Sarah ^b   Hartnell, Sara ^b   Donald, Sarah ^b   Davenport, Katy ^b   Simmons, David ^b   Evans, Mark ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acarbose; Continuous subcutaneous insulin infusion; Hypoglycaemia; Insulin pump; Post prandial hyperglycaemia; Type 1 diabetes

Indexed keywords

ACARBOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CASE REPORT; CONTINUOUS INFUSION; DRUG DOSE INCREASE; EDUCATION PROGRAM; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

ACARBOSE; ADULT; ALPHA-GLUCOSIDASES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 84857234909     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.11.008     Document Type: Article

References (7)

1. Bonora E., Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 2001, 44:2107-2114.
2. Lin H.J., Lee B.C., Ho Y.L., Lin Y.H., Chen C.Y., Hsu H.C., et al. Postprandial glucose improves the risk prediction of cardiovascular death beyond the metabolic syndrome in the nondiabetic population. Diabetes Care 2009, 32:1721-1726.
3. Li C., Hung Y.J., Qamruddin K., Aziz M.F., Stein H., Schmidt B. International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2011, 92:57-64.
4. Riccardi G., Giacco R., Parillo M., Turco S., Rivellese A.A., Ventura M.R., et al. Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study. Diabet Med 1999, 16:228-232.
5. VanDeKoppel S., Choe H.M., Sweet B.V. Managed care perspective on three new agents for type 2 diabetes. J Manag Care Pharm 2008, 14:363-380.
6. Richard J.L., Rodier M., Monnier L., Orsetti A., Mirouze J. Effect of acarbose on glucose and insulin response to sucrose load in reactive hypoglycemia. Diabetes Metab 1988, 14:114-118.
7. King A.B. Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients. Diabetes Technol Ther 2000, 12:105-108.